Gautam Patel sold $651K of Amneal Pharmaceuticals (AMRX)

Executed Feb 3 2025, disclosed Feb 5 2025, 2 days later.

Value, as filed

$651K

80,000 sh × $8.14

Executed

Feb 3 2025

the trade date, as filed

Disclosed

Feb 5 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

GP Gautam Patel Director profile →

Gautam Patel (Director) filed 7 Form 4 reports in the past 24 months (0 purchases, 7 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $761K of AMRX (94,906 sh × $8.02, as filed), executed Jun 16 2025.

The name

AMRX Amneal Pharmaceuticals, Inc. AMRX · Healthcare · 32 filings in 24 months ticker →

Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Gautam Patel in AMRX

AMRXSALE Amneal Pharmaceuticals, Inc. $761K
94,906 sh × $8.02
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $453K
56,426 sh × $8.02
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $664K
80,000 sh × $8.30
Exec Apr 1 2025
Filed Apr 2 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $712K
80,000 sh × $8.90
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $501K
62,590 sh × $8.01
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $139K
17,410 sh × $8.01
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET